Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts

@article{Nakamura2007EstrogenPB,
  title={Estrogen Prevents Bone Loss via Estrogen Receptor $\alpha$ and Induction of Fas Ligand in Osteoclasts},
  author={Takashi Nakamura and Yuuki Imai and Takahiro Matsumoto and Shingo Sato and Kazusane Takeuchi and Katsuhide Igarashi and Yoshifumi Harada and Yoshiaki Azuma and Andrée Krust and Yoko Yamamoto and Hiroshi Nishina and Shu Takeda and Hiroshi Takayanagi and Daniel Metzger and Jun Kanno and Kunio Takaoka and T John Martin and Pierre Chambon and Shigeaki Kato},
  journal={Cell},
  year={2007},
  volume={130},
  pages={811-823}
}

Figures from this paper

The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone.

TLDR
It is concluded that estrogens attenuate osteoclast generation and life span via cell autonomous effects mediated by DNA-binding-independent actions of ERalpha, and elimination of these effects is sufficient for loss of bone in the cancellous compartment.

Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival

TLDR
It is demonstrated that estrogen protects bone by inducing a paracrine signal originating in osteoblasts leading to the death of pre‐osteoclasts and offer an important new target for the prevention and treatment of osteoporosis.

The role of estrogen and androgen receptors in bone health and disease

Mouse models with cell-specific deletion of the estrogen receptor (ER) α, the androgen receptor (AR) or the receptor activator of nuclear factor κB ligand (RANKL), as well as cascade-selective

Estrogens Maintain Bone Mass by Regulating Expression of Genes Controlling Function and Life Span in Mature Osteoclasts

TLDR
In osteoclasts, estrogens function to inhibit bone resorption activity and vitality rather than differentiation, and in vivo estrogens directly regulate the life span of mature osteoclast by inducing the expression of pro‐apoptotic Fas ligand (FasL).

Female Mice Lacking Estrogen Receptor‐Alpha in Osteoblasts Have Compromised Bone Mass and Strength

TLDR
Female osteoblast‐specific ERαKO mice are generated by crossing mice expressing a floxed ERα gene (ERαfl/fl) with mice transgenic for the osteocalcin‐Cre promoter (OC‐Cre), which confirmed that serum levels of estrogen and IGF‐1 were unaltered and focused on relating bone mechanics to skeletal phenotype.

Estrogens decrease osteoclast number by attenuating mitochondria oxidative phosphorylation and ATP production in early osteoclast precursors

TLDR
It is demonstrated that estrogens decrease osteoclast number by attenuating respiration, and thereby, promoting mitochondrial apoptotic death of early osteoporosis progenitors.

Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass

TLDR
Osteoblast-induced osteoclast apoptosis via FASL/FAS signaling is a previously unrecognized mechanism that has an important role in the maintenance of bone mass in both physiological conditions and OVX osteoporosis.

Fas receptor is required for estrogen deficiency-induced bone loss in mice

TLDR
The Fas receptor has an important role in the pathogenesis of postmenopausal osteoporosis by mediating apoptosis and inhibiting differentiation of osteoblast lineage cells, which may be used as a therapeutic target in the treatment of osteoresorptive disorders.

Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual.

TLDR
It is found that ERα in osteoblast progenitors expressing Osterix1 (Osx1) potentiates Wnt/β-catenin signaling, thereby increasing proliferation and differentiation of periosteal cells, and this signaling pathway was required for optimal cortical bone accrual at theperiosteum in mice.

Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice

TLDR
It is proposed that the physiological trabecular bone-sparing effect of estrogen is mediated via ERβ in osteocytes in males, but via ERα in osteoclasts in females, but it is dispensable for the trabECular bone in female mice and the cortical bone in both genders.
...

References

SHOWING 1-10 OF 54 REFERENCES

Suppressive function of androgen receptor in bone resorption

TLDR
It is shown that inactivation of AR in mice using a Cre-loxP system-mediated gene-targeting technique caused bone loss in males but not in females, and results indicate that AR function is indispensable for male-type bone formation and remodeling.

Estrogen Inhibits Bone Resorption by Directly Inducing Apoptosis of the Bone-resorbing Osteoclasts

TLDR
The data suggest that the protective effects of estrogen against postmenopausal osteoporosis are mediated in part by the direct induction of apoptosis of the bone-resorbing osteoclasts by an estrogen receptor– mediated mechanism.

Mechanisms of sex steroid effects on bone.

  • F. SyedS. Khosla
  • Biology, Medicine
    Biochemical and biophysical research communications
  • 2005

A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice.

TLDR
It is concluded that ERalpha is the main effector of estradiol's protective function in bone in both male and female mice, and that, in its absence, AR is not sufficient to mediate this response.

Force‐Induced Osteoclast Apoptosis In Vivo Is Accompanied by Elevation in Transforming Growth Factor β and Osteoprotegerin Expression

  • Y. KobayashiF. Hashimoto H. Sakai
  • Biology
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • 2000
TLDR
There may be a sequential link in tensional force applied on the bone lining cells, up‐regulation of TGF‐β1/OPG, and disappearance of osteoclasts, as suggested in an experimental model of tooth movement in rats.

Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen.

  • G. ZamanH. Jessop Lance L Lanyon
  • Biology
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • 2006
TLDR
Bone cells' responses to both strain and estrogen involve ERalpha, but only estrogen regulates its cellular concentration, consistent with the hypothesis that bone loss associated with estrogen deficiency is a consequence of reduction in ERalpha number/activity associated with lower estrogen concentration reducing the effectiveness of bone cells' anabolic response to strain.

FSH Directly Regulates Bone Mass

Steroid hormone receptor expression and action in bone.

  • R. Bland
  • Biology, Medicine
    Clinical science
  • 2000
TLDR
This review focuses not only on the steroid hormones, but also on related hormones (vitamin D, thyroid hormone and the retinoids), all of which act via structurally homologous nuclear receptors that form part of the steroid/thyroid receptor superfamily.

Osteoclast-derived activity in the coupling of bone formation to resorption.

Elucidation of estrogen receptor function in bone with the use of mouse models

...